Windtree Therapeutics WINT

Quarterly report 2025-Q3
added 11-19-2025

Windtree Therapeutics DIO Ratio 2011-2026 | WINT

Annual DIO Ratio Windtree Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	70.2	44.2	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
70.2	44.2	57.2

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.89	1.48 %	$ 6.54 M	China
	ACADIA Pharmaceuticals ACAD	295	$ 22.2	-2.07 %	$ 3.68 B	USA
	Galapagos NV GLPG	0.915	$ 27.86	-1.97 %	$ 2.69 B	Belgium
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Aquestive Therapeutics AQST	120	$ 4.05	-0.98 %	$ 433 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 22.37	-3.95 %	$ 2.85 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.41	-4.73 %	$ 375 M	Britain
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands